Sciascia David, Neary Paul, Sahebally Shaheel, Whelan Maria, Clancy Cillian, O Riordan James Michael, Abdelgadir Alwaleed, Kavanagh Dara Oliver
Department of Coloretal Surgery, Tallaght University Hospital, Dublin, Ireland.
Dig Surg. 2025;42(1):36-47. doi: 10.1159/000543241. Epub 2024 Dec 28.
This study aims to investigate the current evidence regarding long-term outcomes using laparoscopic peritoneal lavage (LPL) versus primary bowel resection (PR) in Hinchey III diverticulitis.
A systematic review was undertaken based upon articles published between January 1, 2000, and March 1, 2024. Databases Pubmed, Scopus, and Embase were used employing the key search terms "Diverticulitis" and "Peritoneal Lavage." Articles were selected according to the PRISMA guidelines and statistical analysis was undertaken. Cumulative analysis of diverticulitis recurrence and secondary outcomes of disease-related mortality, serious adverse events, stoma incidence, reoperation, and readmission rates were performed.
An initial search identified 506 articles for review. A total of 294 patients were included for final analysis from 3 prospective randomized controlled trials. There was no significant difference in disease-related mortality or serious adverse events between LPL and PR. There was significantly decreased likelihood of having a stoma in the LPL group; however, there was also a significantly increased likelihood of having recurrent diverticulitis. There was heterogenicity across all trials.
There is a paucity of level 1 evidence available regarding the long-term outcomes of Hinchey III diverticulitis managed with LPL. At 3-year follow-up, there is a significantly decreased likelihood of having a stoma, tempered by the fact that there is a significantly increased likelihood of having recurrent diverticulitis. Further homogenous high-quality randomized studies are required to clarify whether LPL shows long-term benefit over PR.
本研究旨在调查关于在辛奇 III 型憩室炎中使用腹腔镜腹膜灌洗(LPL)与一期肠切除术(PR)的长期预后的现有证据。
基于2000年1月1日至2024年3月1日发表的文章进行系统评价。使用数据库PubMed、Scopus和Embase,采用关键检索词“憩室炎”和“腹膜灌洗”。根据PRISMA指南选择文章并进行统计分析。对憩室炎复发以及疾病相关死亡率、严重不良事件、造口发生率、再次手术和再入院率等次要结局进行累积分析。
初步检索确定了506篇文章以供审查。最终分析纳入了来自3项前瞻性随机对照试验的294例患者。LPL组和PR组在疾病相关死亡率或严重不良事件方面无显著差异。LPL组造口的可能性显著降低;然而,憩室炎复发的可能性也显著增加。所有试验均存在异质性。
关于LPL治疗辛奇III型憩室炎的长期预后,缺乏一级证据。在3年随访中,造口的可能性显著降低,但憩室炎复发的可能性显著增加。需要进一步开展同质的高质量随机研究,以明确LPL是否比PR具有长期优势。